User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Feb 07 2016 12:42 IST RSS 2.0
 
1 to 20 of 2,668    
The pill that costs $9,000 in US sells for $70 in India 7.2.2016 ET: Pharma
Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the US.
Also found in: [+]
Nirmala Sitharaman asks pharmaceutical industry to reduce dependence on API imports 5.2.2016 DNA: Recent Columns
Commerce and Industry Minister Nirmala Sitharaman on Friday raised serious concerns over increasing imports of Active Pharmaceutical Ingredients (APIs) and asked the experts and industry to work in the direction to reduce the dependence on imports. "When we are setting up pharmaceutical and biotechnology hubs... the dependence on imported APIs worries me a lot," she said at the Global Biotechnology Summit. Sitharaman said as India is a global hub of generic medicines and biotechnology centres, industry, academia and experts should work in reducing the increasing imports. India is hugely dependent on China for import of the APIs, which are the raw materials for medicines. Indian firms imported APIs and intermediates worth nearly $3 billion (nearly Rs 20,343 crore) in 2010-11 with China alone accounting for $1.88 billion (nearly Rs 12,748.28 crore).  The minister said both developing and developed countries are dependent on India for affordable generic medicines. Further, the Commerce Ministry is ...
Also found in: [+]
Dependence on imported APIs is worrisome: Nirmala Sitharaman 5.2.2016 ET: Foreign Trade
Commerce and industry Minister Nirmala Sitharaman today raised serious concerns over increasing imports of active pharmaceutical ingredients.
Also found in: [+]
Dr. Harsh Vardhan inaugurates the “MAGIC” process lab at CSIR-National Chemical Laboratory, Pune 3.2.2016 Govt of india: PIB
The Union Minister for Science & Technology & Earth Sciences, Dr Harsh Vardhan, inaugurated a unique MAGIC [Modular, Agile, Intensified & Continuous] Process Lab at CSIR-National Chemical Laboratory (CSIR-NCL) Pune last evening. While inaugurating the facility he announced that “The MAGIC processes and plants will bring about a paradigm shift in the way in which India’s Fine and Specialty Chemicals industry will operate in the future.
Also found in: [+]
Sun hopes cut-price generic Gleevec will win third of U.S. market 2.2.2016 Sify Finance
ZURICH (Reuters) - India's Sun Pharma launched a generic version of Novartis's leukaemia drug Gleevec on Monday in the United States and hopes to poach a third of sales in six
Also found in: [+]
Sensible eating can keep India fit: GSK CEO 28.1.2016 TOI: India Business
The best way for any country to ensure the well-being of its people is to see that they follow an active lifestyle, eat sensibly and generally follow the precepts of prevention.
Also found in: [+]
SC agrees to hear Cipla’s plea against La Roche 28.1.2016 TOI: India Business
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging the Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche’s patent over lung cancer drug Erlotinib.
Also found in: [+]
ET GBS: Active lifestyle, sensible eating can keep India fit, says GlaxoSmithKline CEO Andrew Witty 28.1.2016 ET: Policy
The best way for any country to ensure the well-being of its people is to see that they follow an active lifestyle, eat sensibly and generally follow the precepts of prevention.
Also found in: [+]
Supreme Court agrees to hear Cipla’s plea against La Roche 27.1.2016 TOI: India
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche. Roche’s patent over lung cancer drug ...
Also found in: [+]
Big Pharma’s worst nightmare | Sarah Boseley 26.1.2016 The Guardian -- Front Page
Jamie Love has spent years battling global drug companies, unshakable in his belief that even the world’s poorest people should have access to life-saving medicines. Is it time that our own government listened to him? On a hot August afternoon in 2000, four Americans arrived for a secret meeting at the central London penthouse flat of an Indian billionaire drug manufacturer named Yusuf Hamied. A sixth person would join them there, a French employee of the World Health Organisation, who was flying in from Geneva, having told his colleagues he was taking leave. Hamied took his guests into the dining room on the seventh floor. The room featured a view of the private gardens of Gloucester Square, Bayswater, for which only the residents possess a key. The six men sat round a glass dining table overlooked by a painting of galloping horses by a Mumbai artist (Hamied has racehorses stabled in three cities). The discussion, which went on all afternoon and through dinner that evening at the Bombay Palace ...
Also found in: [+]
EU trademark norms may hit Indian drug exports 26.1.2016 TOI: India Business
Faced with seizures of crucial drug consignments originating from the country, India had earlier raised the issue with the WTO dispute settlement mechanism against the EU.
Also found in: [+]
India rejects licence plea for AstraZeneca's anti-diabetic drug 20.1.2016 ET: Pharma
The Indian patent office has rejected Hyderabad-based Lee Pharma's application for a compulsory licence on AstraZeneca's anti-diabetic medicine saxagliptin.
Also found in: [+]
India rejects compulsory license application of Lee Pharma against AstraZeneca’s Saxagliptin 20.1.2016 ET: Pharma
The Indian Patent Office has rejected the application of Lee Pharma for a compulsory license on AstraZeneca’s anti-diabetes drug saxagliptin branded as Onglyza.
Also found in: [+]
Internet is creating the digital divide, says Amartya Sen 7.1.2016 Rediff: Business
Free Basics offers a limited version of the Internet on mobile phones.
Also found in: [+]
Sensex down 28 points amid lackluster trades 5.1.2016 Sify Finance
Also found in: [+]
Make way for automatic compulsory licencing in pharma: RSS 3.1.2016 ET: Pharma
Noting that India is known as the 'Pharmacy of the World' for providing cheap medicines for those affected by blood cancer, HIV-AIDS and other serious diseases, SJM said it should frame policies responsibly.
Also found in: [+]
How some SC judgements changed the game for corporate India 28.12.2015 Rediff: Business
The 1995 judgment in the Union of India vs Cricket Association of Bengal case emphasised that free speech is essential for a successful democracy and citizens must have a plurality of views and a range of opinions on all public issues, says M J Antony.
Also found in: [+]
WTO gets strict over patent extension 24.12.2015 TOI: India Business
The government on Wednesday said WTO member countries have agreed to “prevent evergreening” of patents in pharmaceuticals, a move that will help the entry of generic medicines into the market by ensuring that Big Pharma does not tweak the composition of drugs to extend the validity of a patent.
Also found in: [+]
India to pursue food security issue with greater vigour at WTO 23.12.2015 ET: Foreign Trade
The minister said she was "utterly disappointed" because with one voice, the WTO could not reaffirm the Doha Developmental Agenda.
Also found in: [+]
Celgene to allow sale of generic Revlimid before patent expiry 23.12.2015 Sify Finance
Dec 22 (Reuters) - Celgene Corp said it would allow the sale of a generic version of its flagship multiple myeloma drug, Revlimid, in the United States more than a year before the drug's patent
Also found in: [+]
1 to 20 of 2,668